<DOC>
	<DOCNO>NCT02387619</DOCNO>
	<brief_summary>A randomized , open-label , multiple-dose , crossover study investigate pharmacokinetic drug interaction rosuvastatin telmisartan/amlodipine healthy male volunteer</brief_summary>
	<brief_title>The Pharmacokinetic Drug Interaction Between Rosuvastatin Telmisartan/Amlodipine</brief_title>
	<detailed_description>A randomized , open-label , 2-treatment , 2-sequence , 2-period , multiple-dose , crossover design</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>19~55 year healthy male Body weight 55kg , The result Body Mass Index ( BMI ) less 18 kg/m2 , 27 kg/m2 Subjects agree keep contraceptive method clinical trial . Subjects allergic investigational drug . Subjects medical history affect clinical trial . Hypertension ( Systolic BP ≥ 150mmHG Diastolic BP ≥ 100mmHg ) , Hypotension ( Systolic BP ≤ 100mmHg Diastolic BP ≤ 65mmHg ) Liver enzyme ( AST , ALT ) level exceeds maximum normal range one half time .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>